Kalbe Farma Tbk vs Semen Indonesia (Persero) Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Semen Indonesia (Persero) Tbk. trades at Rp1,495 (market cap 9.79T, 37.71M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 3.4× Semen Indonesia (Persero) Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 37.71M). Which is the better fit depends on your goals.
| KLBF | SMGR | |
|---|---|---|
Market Cap | 33T | 9.79T |
Volume | 98.44M | 37.71M |
Lot | 984.38K | 377.05K |
Turnover | 70.64B | 55.54B |
Average Price | 717.58 | 1,473.06 |
Value | 70.64B | 55.54B |
Indicative Equilibrium Price | 720 | 1,495 |
Indicative Equilibrium Volume | 43.62K | 4.92K |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Semen Indonesia (Persero) Tbk was established on March 25,1953 as NV Pabrik Semen Gresik. On April 17, 1961,NV Pabrik Semen Gresik was transformed into a state enterprise (Persero) by Government Regulation No. 132 year 1961, and subsequently became PT Semen Gresik (Persero). Semen Gresik is a cement producer which was formerly fully owned by the government. On July 1995 the company shareholders meeting agreed to acquired 100% share of two state owned cement producer companies, namely PT. Semen Tonasa and PT. Semen Padang.
Read more on SMGR →